Do analysts rate COSM or YI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 111 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, COSM or YI?

111 has higher revenue and earnings than Cosmos Health. 111 is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cosmos Health $65.27M 0.35 -$19.15M -$0.64 N/A 111 $1.80B 0.02 -$9.65M -$1.40 N/A

Is COSM or YI more profitable?

111 has a net margin of -0.76% compared to Cosmos Health's net margin of -33.08%. 111's return on equity of 0.00% beat Cosmos Health's return on equity. Company Net Margins Return on Equity Return on Assets Cosmos Health -33.08% -56.88% -18.03% 111 -0.76% N/A -3.80%

Does the media favor COSM or YI?

In the previous week, Cosmos Health had 4 more articles in the media than 111. MarketBeat recorded 6 mentions for Cosmos Health and 2 mentions for 111. 111's average media sentiment score of 0.94 beat Cosmos Health's score of 0.92 indicating that 111 is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cosmos Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 111 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate COSM or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, COSM or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Cosmos Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cosmos Health $65.27M 0.35 -$19.15M -$0.64 N/A Hong Kong Pharma Digital Technology $13.43M 0.28 -$1.14M N/A N/A

Do analysts prefer COSM or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor COSM or MEDS?

In the previous week, Cosmos Health had 5 more articles in the media than Wellgistics Health. MarketBeat recorded 6 mentions for Cosmos Health and 1 mentions for Wellgistics Health. Cosmos Health's average media sentiment score of 0.92 beat Wellgistics Health's score of 0.67 indicating that Cosmos Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cosmos Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Wellgistics Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend COSM or RDGT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, COSM or RDGT?

Ridgetech has higher revenue and earnings than Cosmos Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cosmos Health $65.27M 0.35 -$19.15M -$0.64 N/A Ridgetech $132.16M 0.03 -$1.25M N/A N/A

Do analysts rate MCK or COSM?

McKesson presently has a consensus price target of $973.44, indicating a potential upside of 8.69%. Given McKesson's stronger consensus rating and higher probable upside, research analysts clearly believe McKesson is more favorable than Cosmos Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score McKesson 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.78 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, MCK or COSM?

McKesson has higher revenue and earnings than Cosmos Health. Cosmos Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.26 $4.76B $37.37 23.97 Cosmos Health $65.27M 0.35 -$19.15M -$0.64 N/A

Is MCK or COSM more profitable?

McKesson has a net margin of 1.12% compared to Cosmos Health's net margin of -33.08%. Cosmos Health's return on equity of -56.88% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% Cosmos Health -33.08% -56.88% -18.03%

Does the media refer more to MCK or COSM?

In the previous week, McKesson had 68 more articles in the media than Cosmos Health. MarketBeat recorded 74 mentions for McKesson and 6 mentions for Cosmos Health. McKesson's average media sentiment score of 1.35 beat Cosmos Health's score of 0.92 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 63 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cosmos Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cosmos Health (COSM) Competitors

$0.22 0.00 (0.00%)

Closing price 08/28/2026 04:00 PM Eastern

Extended Trading

$0.23 +0.00 (+1.47%)

As of 05:43 AM Eastern

Compare

COSM vs. YI, HKPD, MEDS, RDGT, and MCK

Should you buy Cosmos Health stock or one of its competitors? Cosmos Health's main competitors and comparable companies include 111 (YI), Hong Kong Pharma Digital Technology (HKPD), Wellgistics Health (MEDS), Ridgetech (RDGT), and McKesson (MCK). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Cosmos Health compare to 111?

Cosmos Health (NASDAQ:COSM) and 111 (NASDAQ:YI) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 21.3% of 111 shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by company insiders. Comparatively, 43.9% of 111 shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Cosmos Health had 4 more articles in the media than 111. MarketBeat recorded 6 mentions for Cosmos Health and 2 mentions for 111. 111's average media sentiment score of 0.94 beat Cosmos Health's score of 0.92 indicating that 111 is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cosmos Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
111	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cosmos Health has a beta of 4.8, suggesting that its stock price is 380% more volatile than the broader market. Comparatively, 111 has a beta of 0.67, suggesting that its stock price is 33% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
111	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

111 has higher revenue and earnings than Cosmos Health. 111 is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$65.27M	0.35	-$19.15M	-$0.64	N/A
111	$1.80B	0.02	-$9.65M	-$1.40	N/A

111 has a net margin of -0.76% compared to Cosmos Health's net margin of -33.08%. 111's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-33.08%	-56.88%	-18.03%
111	-0.76%	N/A	-3.80%

Summary

111 beats Cosmos Health on 8 of the 13 factors compared between the two stocks.

How does Cosmos Health compare to Hong Kong Pharma Digital Technology?

Cosmos Health (NASDAQ:COSM) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Cosmos Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$65.27M	0.35	-$19.15M	-$0.64	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.28	-$1.14M	N/A	N/A

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Cosmos Health's net margin of -33.08%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-33.08%	-56.88%	-18.03%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

Cosmos Health has a beta of 4.8, suggesting that its share price is 380% more volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.33, suggesting that its share price is 133% more volatile than the broader market.

In the previous week, Cosmos Health had 5 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 6 mentions for Cosmos Health and 1 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 1.87 beat Cosmos Health's score of 0.92 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
Cosmos Health	Positive
Hong Kong Pharma Digital Technology	Very Positive

12.6% of Cosmos Health shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Cosmos Health beats Hong Kong Pharma Digital Technology on 6 of the 11 factors compared between the two stocks.

How does Cosmos Health compare to Wellgistics Health?

Cosmos Health (NASDAQ:COSM) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.

Cosmos Health has higher revenue and earnings than Wellgistics Health. Cosmos Health is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$65.27M	0.35	-$19.15M	-$0.64	N/A
Wellgistics Health	$23.34M	0.13	-$101.28M	-$46.13	N/A

12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by insiders. Comparatively, 27.0% of Wellgistics Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Cosmos Health has a net margin of -33.08% compared to Wellgistics Health's net margin of -1,100.16%. Wellgistics Health's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-33.08%	-56.88%	-18.03%
Wellgistics Health	-1,100.16%	N/A	-171.81%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Cosmos Health had 5 more articles in the media than Wellgistics Health. MarketBeat recorded 6 mentions for Cosmos Health and 1 mentions for Wellgistics Health. Cosmos Health's average media sentiment score of 0.92 beat Wellgistics Health's score of 0.67 indicating that Cosmos Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cosmos Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Wellgistics Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cosmos Health has a beta of 4.8, indicating that its share price is 380% more volatile than the broader market. Comparatively, Wellgistics Health has a beta of -1.54, indicating that its share price is 254% less volatile than the broader market.

Summary

Cosmos Health beats Wellgistics Health on 10 of the 13 factors compared between the two stocks.

How does Cosmos Health compare to Ridgetech?

Cosmos Health (NASDAQ:COSM) and Ridgetech (NASDAQ:RDGT) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 45.3% of Ridgetech shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by insiders. Comparatively, 22.6% of Ridgetech shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Cosmos Health has a beta of 4.8, suggesting that its share price is 380% more volatile than the broader market. Comparatively, Ridgetech has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market.

Ridgetech has a net margin of 0.00% compared to Cosmos Health's net margin of -33.08%. Ridgetech's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-33.08%	-56.88%	-18.03%
Ridgetech	N/A	N/A	N/A

In the previous week, Cosmos Health had 4 more articles in the media than Ridgetech. MarketBeat recorded 6 mentions for Cosmos Health and 2 mentions for Ridgetech. Cosmos Health's average media sentiment score of 0.92 beat Ridgetech's score of 0.43 indicating that Cosmos Health is being referred to more favorably in the media.

Company	Overall Sentiment
Cosmos Health	Positive
Ridgetech	Neutral

Ridgetech has higher revenue and earnings than Cosmos Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$65.27M	0.35	-$19.15M	-$0.64	N/A
Ridgetech	$132.16M	0.03	-$1.25M	N/A	N/A

Summary

Ridgetech beats Cosmos Health on 6 of the 11 factors compared between the two stocks.

How does Cosmos Health compare to McKesson?

McKesson (NYSE:MCK) and Cosmos Health (NASDAQ:COSM) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

In the previous week, McKesson had 68 more articles in the media than Cosmos Health. MarketBeat recorded 74 mentions for McKesson and 6 mentions for Cosmos Health. McKesson's average media sentiment score of 1.35 beat Cosmos Health's score of 0.92 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	63 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cosmos Health	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

McKesson has a net margin of 1.12% compared to Cosmos Health's net margin of -33.08%. Cosmos Health's return on equity of -56.88% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Cosmos Health	-33.08%	-56.88%	-18.03%

McKesson has higher revenue and earnings than Cosmos Health. Cosmos Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.26	$4.76B	$37.37	23.97
Cosmos Health	$65.27M	0.35	-$19.15M	-$0.64	N/A

McKesson presently has a consensus price target of $973.44, indicating a potential upside of 8.69%. Given McKesson's stronger consensus rating and higher probable upside, research analysts clearly believe McKesson is more favorable than Cosmos Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

McKesson has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.8, indicating that its share price is 380% more volatile than the broader market.

85.1% of McKesson shares are held by institutional investors. Comparatively, 12.6% of Cosmos Health shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Comparatively, 26.2% of Cosmos Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

McKesson beats Cosmos Health on 12 of the 16 factors compared between the two stocks.

Get Cosmos Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COSM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COSM vs. The Competition

Export

Metric	Cosmos Health	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$22.61M	$9.83B	$7.18B	$12.88B
Dividend Yield	N/A	2.56%	2.54%	11.27%
P/E Ratio	-0.35	34.42	273.17	25.45
Price / Sales	0.35	5.01	638.13	103.78
Price / Cash	N/A	24.48	28.74	36.03
Price / Book	0.50	5.30	11.08	6.36
Net Income	-$19.15M	$310.63M	$3.48B	$349.79M
7 Day Performance	8.76%	-0.48%	0.21%	-0.48%
1 Month Performance	4.22%	1.18%	7.75%	4.17%
1 Year Performance	-71.56%	15.34%	24.68%	15.11%

Cosmos Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COSM Cosmos Health	1.8581 of 5 stars	$0.22 flat	N/A	-71.6%	$22.61M	$65.27M	N/A	100
YI 111	0.9606 of 5 stars	$3.65 +3.3%	N/A	-46.2%	$32.05M	$1.80B	N/A	1,063
HKPD Hong Kong Pharma Digital Technology	1.0193 of 5 stars	$0.40 +7.0%	N/A	-77.0%	$4.38M	$13.43M	N/A	19	Gap Down
MEDS Wellgistics Health	0.0932 of 5 stars	$1.36 +4.6%	N/A	-98.4%	$3.99M	$8.02M	N/A	31
RDGT Ridgetech	0.7423 of 5 stars	$0.82 +4.2%	N/A	-99.5%	$2.99M	$132.16M	N/A	980

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:COSM) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cosmos Health (COSM) Competitors

COSM vs. YI, HKPD, MEDS, RDGT, and MCK

How does Cosmos Health compare to 111?

Summary

How does Cosmos Health compare to Hong Kong Pharma Digital Technology?

Summary

How does Cosmos Health compare to Wellgistics Health?

Summary

How does Cosmos Health compare to Ridgetech?

Summary

How does Cosmos Health compare to McKesson?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COSM vs. The Competition

Cosmos Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cosmos Health (COSM) Competitors

COSM vs. YI, HKPD, MEDS, RDGT, and MCK

How does Cosmos Health compare to 111?

Do insiders & institutionals hold more shares of COSM or YI?

Does the media favor COSM or YI?

Which has more risk & volatility, COSM or YI?

Do analysts rate COSM or YI?

Which has stronger valuation & earnings, COSM or YI?

Is COSM or YI more profitable?

Summary

How does Cosmos Health compare to Hong Kong Pharma Digital Technology?

Which has preferable valuation and earnings, COSM or HKPD?

Is COSM or HKPD more profitable?

Which has more volatility and risk, COSM or HKPD?

Does the media favor COSM or HKPD?

Do institutionals & insiders hold more shares of COSM or HKPD?

Do analysts rate COSM or HKPD?

Summary

How does Cosmos Health compare to Wellgistics Health?

Which has stronger valuation and earnings, COSM or MEDS?

Do insiders and institutionals hold more shares of COSM or MEDS?

Is COSM or MEDS more profitable?

Do analysts prefer COSM or MEDS?

Does the media favor COSM or MEDS?

Which has more risk & volatility, COSM or MEDS?

Summary

How does Cosmos Health compare to Ridgetech?

Do analysts recommend COSM or RDGT?

Do insiders and institutionals believe in COSM or RDGT?

Which has more volatility & risk, COSM or RDGT?

Is COSM or RDGT more profitable?

Does the media favor COSM or RDGT?

Which has higher earnings and valuation, COSM or RDGT?

Summary

How does Cosmos Health compare to McKesson?

Does the media refer more to MCK or COSM?

Is MCK or COSM more profitable?

Which has better valuation and earnings, MCK or COSM?

Do analysts rate MCK or COSM?

Which has more risk and volatility, MCK or COSM?

Do institutionals and insiders have more ownership in MCK or COSM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COSM vs. The Competition

Cosmos Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools